VanEck Pharmaceutical ETF Stock Forecast, Price & News

-0.49 (-0.66 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume70,993 shs
Average Volume84,026 shs
Market Capitalization$324.95 million
P/E RatioN/A
Dividend Yield1.56%
30 days | 90 days | 365 days | Advanced Chart
Receive PPH News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Van Eck
Fund NameVanEck Pharmaceutical ETF
Tax ClassificationRegulated Investment Company
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index
FocusHealth Care
Development LevelDeveloped Markets

Fund Statistics

Assets Under Management$321.10 million
Average Daily Volume$32,337.00

ETF Expenses

Management Fee0.35%
Other Expenses0.05%
Total Expenses0.40%
Fee Waiver-0.05%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianState Street Bank and Trust Company
DistributorVan Eck Securities Corporation
Transfer AgentState Street Bank and Trust Company
Lead Market Maker

Geographic Exposure of PPH

Currency Exposure of PPH

Sector Exposure of PPH

Industry Exposure of PPH

speech bubbles
speech bubbles

VanEck Pharmaceutical ETF (NYSEARCA:PPH) Frequently Asked Questions

What stocks does MarketBeat like better than VanEck Pharmaceutical ETF?

Wall Street analysts have given VanEck Pharmaceutical ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but VanEck Pharmaceutical ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Is VanEck Pharmaceutical ETF a good dividend stock?

VanEck Pharmaceutical ETF pays an annual dividend of $1.15 per share and currently has a dividend yield of 1.56%.
View VanEck Pharmaceutical ETF's dividend history.

What other stocks do shareholders of VanEck Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Pfizer (PFE), Comcast (CMCSA), Gilead Sciences (GILD), The Home Depot (HD), McDonald's (MCD), The Procter & Gamble (PG), AT&T (T), Abbott Laboratories (ABT), ARK Genomic Revolution Multi-Sector ETF (ARKG) and Bank of America (BAC).

What is VanEck Pharmaceutical ETF's stock symbol?

VanEck Pharmaceutical ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PPH."

How do I buy shares of VanEck Pharmaceutical ETF?

Shares of PPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VanEck Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $73.22.

How much money does VanEck Pharmaceutical ETF make?

VanEck Pharmaceutical ETF has a market capitalization of $324.95 million.

This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.